Literature DB >> 34040157

Enhanced heroin self-administration and distinct dopamine adaptations in female rats.

Brianna E George1, Samuel H Barth1, Lindsey B Kuiper1, Katherine M Holleran1, Ryan T Lacy2, Kimberly F Raab-Graham1, Sara R Jones3.   

Abstract

Increasing evidence suggests that females are more vulnerable to the harmful effects of drugs of abuse, including opioids. Additionally, rates of heroin-related deaths substantially increased in females from 1999 to 2017 [1], underscoring the need to evaluate sex differences in heroin vulnerability. Moreover, the neurobiological substrates underlying sexually dimorphic responding to heroin are not fully defined. Thus, we evaluated male and female Long Evans rats on acquisition, dose-responsiveness, and seeking for heroin self-administration (SA) as well as using a long access model to assess escalation of intake at low and high doses of heroin, 0.025 and 0.1 mg/kg/inf, respectively. We paired this with ex vivo fast-scan cyclic voltammetry (FSCV) in the medial nucleus accumbens (NAc) shell and quantification of mu-opioid receptor (MOR) protein in the ventral tegmental area (VTA) and NAc. While males and females had similar heroin SA acquisition rates, females displayed increased responding and intake across doses, seeking for heroin, and escalation on long access. However, we found that males and females had similar expression levels of MORs in the VTA and NAc, regardless of heroin exposure. FSCV results revealed that heroin exposure did not change single-pulse elicited dopamine release, but caused an increase in dopamine transporter activity in both males and females compared to their naïve counterparts. Phasic-like stimulations elicited robust increases in dopamine release in heroin-exposed females compared to heroin-naïve females, with no differences seen in males. Together, our results suggest that differential adaptations of dopamine terminals may underlie the increased heroin SA behaviors seen in females.
© 2021. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34040157      PMCID: PMC8358024          DOI: 10.1038/s41386-021-01035-0

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  79 in total

1.  Morphine responses in humans: a retrospective analysis of sex differences.

Authors:  J P Zacny
Journal:  Drug Alcohol Depend       Date:  2001-06-01       Impact factor: 4.492

Review 2.  Relationship between Nonmedical Prescription-Opioid Use and Heroin Use.

Authors:  Wilson M Compton; Christopher M Jones; Grant T Baldwin
Journal:  N Engl J Med       Date:  2016-01-14       Impact factor: 91.245

3.  The differences between male and female drug users: community samples of heroin and cocaine users compared.

Authors:  B Powis; P Griffiths; M Gossop; J Strang
Journal:  Subst Use Misuse       Date:  1996-04       Impact factor: 2.164

4.  Trends in heroin and pharmaceutical opioid overdose deaths in Australia.

Authors:  Amanda Roxburgh; Wayne D Hall; Timothy Dobbins; Natasa Gisev; Lucinda Burns; Sallie Pearson; Louisa Degenhardt
Journal:  Drug Alcohol Depend       Date:  2017-08-14       Impact factor: 4.492

5.  Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice.

Authors:  Yong Zhang; Roberto Picetti; Eduardo R Butelman; Ann Ho; Julie A Blendy; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

6.  Gender differences in narcotic-induced emesis in the ED.

Authors:  Leslie S Zun; La Vonne A Downey; William Gossman; Jason Rosenbaumdagger; Glen Sussman
Journal:  Am J Emerg Med       Date:  2002-05       Impact factor: 2.469

7.  Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats.

Authors:  W J Lynch; M E Carroll
Journal:  Psychopharmacology (Berl)       Date:  1999-05       Impact factor: 4.530

8.  Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London.

Authors:  Matthew Hickman; Zenobia Carnwath; Peter Madden; Michael Farrell; Cleone Rooney; Richard Ashcroft; Ali Judd; Gerry Stimson
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

9.  Intravenous cocaine and heroin self-administration in rats selectively bred for differential saccharin intake: phenotype and sex differences.

Authors:  Marilyn E Carroll; Andrew D Morgan; Wendy J Lynch; Una C Campbell; Nancy K Dess
Journal:  Psychopharmacology (Berl)       Date:  2002-03-27       Impact factor: 4.530

10.  Male and female mice develop escalation of heroin intake and dependence following extended access.

Authors:  Eleanor B Towers; Brendan J Tunstall; Mandy L McCracken; Leandro F Vendruscolo; George F Koob
Journal:  Neuropharmacology       Date:  2019-03-14       Impact factor: 5.273

View more
  6 in total

1.  Novelty-induced locomotor behavior predicts heroin addiction vulnerability in male, but not female, rats.

Authors:  Brittany N Kuhn; Nazzareno Cannella; Ayteria D Crow; Analyse T Roberts; Veronica Lunerti; Carter Allen; Rusty W Nall; Gary Hardiman; Leah C Solberg Woods; Dongjun Chung; Roberto Ciccocioppo; Peter W Kalivas
Journal:  Psychopharmacology (Berl)       Date:  2022-09-16       Impact factor: 4.415

2.  Morphine reduces the interest for natural rewards.

Authors:  Alessandro Piccin; Gilles Courtand; Angelo Contarino
Journal:  Psychopharmacology (Berl)       Date:  2022-04-08       Impact factor: 4.415

3.  Sex Differences in Behavioral Responding and Dopamine Release during Pavlovian Learning.

Authors:  Merridee J Lefner; Mariana I Dejeux; Matthew J Wanat
Journal:  eNeuro       Date:  2022-03-22

4.  Histone H3 dopaminylation in ventral tegmental area underlies heroin-induced transcriptional and behavioral plasticity in male rats.

Authors:  Sasha L Fulton; Swarup Mitra; Ashley E Lepack; Jennifer A Martin; Andrew F Stewart; Jacob Converse; Mason Hochstetler; David M Dietz; Ian Maze
Journal:  Neuropsychopharmacology       Date:  2022-01-29       Impact factor: 8.294

5.  Accurate and stable chronic in vivo voltammetry enabled by a replaceable subcutaneous reference electrode.

Authors:  Elaine Marie Robbins; Elisa Castagnola; Xinyan Tracy Cui
Journal:  iScience       Date:  2022-08-02

6.  Altered Accumbal Dopamine Terminal Dynamics Following Chronic Heroin Self-Administration.

Authors:  Brianna E George; Monica H Dawes; Emily G Peck; Sara R Jones
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.